Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 16714-927

5 FDA label images from Northstar Rxllc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 16714-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient Azacitidine. The structure shows the molecular arrangement including nitrogen, oxygen, and hydroxyl groups characteristic of Azacitidine.*
FDA Label Image

Graph (Graph)

Graph (Graph)
This is a Kaplan-Meier survival curve chart depicting the proportion of survival over time (months) from randomization. The chart compares two groups labeled AZA and CCR, showing survival probability on the y-axis and time on the x-axis. The graph includes statistical data such as Log-Rank p-value, hazard ratio with confidence interval, and number of deaths for each group. A risk table below the chart shows the number of subjects at risk at different time points for both groups.*
FDA Label Image

Vial (Vial)

Vial (Vial)
Label for Azacitidine For Injection 100 mg/vial, a lyophilized powder requiring dilution for intravenous or subcutaneous use. The label identifies it as a cytotoxic agent and specifies it is a single-dose vial. Manufactured by NorthStar Rx LLC and Dr. Reddy's Laboratories Limited, with storage instructions and barcode also shown.*
FDA Label Image

Carton (Carton)

Carton (Carton)
Azacitidine For Injection 100 mg/vial lyophilized powder for solution label. The label states the product is for subcutaneous and intravenous use only, and is a cytotoxic agent. It is packaged as a single-dose vial and must be diluted before use. Manufactured by Dr. Reddy's Laboratories Limited for NorthStar Rx LLC.*
FDA Label Image

Cartonfto11 (Cartonfto11)

Cartonfto11 (Cartonfto11)
Packaging label for Azacitidine Injection, 100 mg/vial, a lyophilized powder for solution administered subcutaneously or intravenously. The label notes it as a cytotoxic agent and single-dose vial. Manufactured by Dr. Reddy's Laboratories, labeled for NorthStar Rx LLC, with storage instructions and barcode included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.